Pneumology - Original Articles

Role of hybrid virtual pulmonary rehabilitation in improving performance status of patients eligible for lung transplantation

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Received: 8 January 2025
Accepted: 20 January 2025
Published: 17 October 2025
119
Views
88
Downloads

Authors

Pulmonary rehabilitation (PR) in chronic respiratory diseases improves symptoms, quality of life, and exercise capacity and has an integral role in lung transplantation (LT). Virtual PR has recently emerged to cater to patients who otherwise may not have regular access to PR. However, little is known about the effect of virtual PR strategies on candidates for LT. The primary objective was to study the effect of a protocolized hybrid PR program on performance status using the Karnofsky Performance Status (KPS) score. Secondary objectives were Eastern Cooperative Oncology Group (ECOG) status, quality of life, symptom severity, sarcopenia, spirometry (pulmonary function test and diffusing capacity of the lung for carbon monoxide), 6-minute walk distance, and eligibility for LT waitlisting. This is a prospective, single-arm, interventional study on patients with end-stage lung disease, meeting referral criteria for LT. A protocolized 12-week hybrid hospital and home-based virtual PR intervention was conducted, and all outcomes were assessed at baseline and at completion of the intervention. A total of 75 patients were enrolled, and the intervention was completed by 51 patients (68%). A total of 35 patients met LT listing criteria, 27 being “unfit” for LT at baseline, 18 of whom completed the intervention. Significant improvement was seen in KPS, ECOG, St. George's Respiratory Questionnaire score, visual analogue scale score for cough and dyspnoea, and sarcopenia for all 51 patients. Of the 18 patients unfit for waitlisting, 12 became fit, and 7 were waitlisted for LT. Patients eligible for LT who do not have access to regular PR may benefit from a hybrid (virtual and hospital-based) PR program, with improvement in KPS, quality of life, sarcopenia, and eligibility for LT waitlisting.

Downloads

Download data is not yet available.

Citations

Singer JP, Katz PP, Soong A, et al. Effect of lung transplantation on health-related quality of life in the era of the lung allocation score: a U.S. prospective cohort study. Am J Transplant 2017;17:1334-45. DOI: https://doi.org/10.1111/ajt.14081
Thabut G, Mal H. Outcomes after lung transplantation. J Thorac Dis 2017;9:2684-91. DOI: https://doi.org/10.21037/jtd.2017.07.85
Hoffman M, Chaves G, Ribeiro-Samora GA, et al. Effects of pulmonary rehabilitation in lung transplant candidates: a systematic review. BMJ Open 2017;7:e013445. DOI: https://doi.org/10.1136/bmjopen-2016-013445
Perch M, Hayes D, Cherikh WS, et al. The international thoracic organ transplant registry of the International Society for Heart and Lung Transplantation: thirty-ninth adult lung transplantation report-2022; focus on lung transplant recipients with chronic obstructive pulmonary disease. J Heart Lung Transplant 2022;41:1335-47. DOI: https://doi.org/10.1016/j.healun.2022.08.007
Titman A, Rogers CA, Bonser RS, et al. Disease-specific survival benefit of lung transplantation in adults: a national cohort study. Am J Transplant 2009;9:1640-9. DOI: https://doi.org/10.1111/j.1600-6143.2009.02613.x
Liu V, Zamora MR, Dhillon GS, Weill D. Increasing lung allocation scores predict worsened survival among lung transplant recipients. Am J Transplant 2010;10:915-20. DOI: https://doi.org/10.1111/j.1600-6143.2009.03003.x
Grimm JC, Valero V, Kilic A, et al. Preoperative performance status impacts perioperative morbidity and mortality after lung transplantation. Ann Thorac Surg 2015;99:482-9. DOI: https://doi.org/10.1016/j.athoracsur.2014.09.038
Leard LE, Holm AM, Valapour M, et al. Consensus document for the selection of lung transplant candidates: an update from the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2021;40:1349-79. DOI: https://doi.org/10.1016/j.healun.2021.07.005
Spruit MA, Singh SJ, Garvey C, et al. An Official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med 2013;188:e13-64. DOI: https://doi.org/10.1164/rccm.201308-1509ST
McCarthy B, Casey D, Devane D, et al. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2015;2015:CD003793. DOI: https://doi.org/10.1002/14651858.CD003793.pub3
Lindenauer PK, Stefan MS, Pekow PS, et al. Association between initiation of pulmonary rehabilitation after hospitalization for COPD and 1-year survival among medicare beneficiaries. JAMA 2020;323:1813-23. DOI: https://doi.org/10.1001/jama.2020.4437
Sood P, Bindra S. Modified Kuppuswamy socioeconomic scale: 2022 update of India. Int J Community Med Public Health 2022;9:3841-4. DOI: https://doi.org/10.18203/2394-6040.ijcmph20222581
Crooks V, Waller S, Smith T, Hahn TJ. The use of the Karnofsky Performance Scale in determining outcomes and risk in geriatric outpatients. J Gerontol 1991;46:M139-44. DOI: https://doi.org/10.1093/geronj/46.4.M139
Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982;5:649-55. DOI: https://doi.org/10.1097/00000421-198212000-00014
Jones PW, Quirk FH, Baveystock CM. The St George’s Respiratory Questionnaire. Respir Med 1991;85:25-31. DOI: https://doi.org/10.1016/S0954-6111(06)80166-6
Chen LK, Woo J, Assantachai P, et al. Asian Working Group for Sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc 2020;21:300-7.e2. DOI: https://doi.org/10.1016/j.jamda.2019.12.012
Rathi V, Tiwari P, Seth S, et al. Profile of patients referred for lung transplant and their transplant-free survival. Lung India 2024;41:265-71. DOI: https://doi.org/10.4103/lungindia.lungindia_515_23
Dowman L, Hill CJ, May A, Holland AE. Pulmonary rehabilitation for interstitial lung disease. Cochrane Database Syst Rev 2021;2021:CD006322. DOI: https://doi.org/10.1002/14651858.CD006322.pub4
Lee AL, Gordon CS, Osadnik CR. Exercise training for bronchiectasis. Cochrane Database Syst Rev 2021;2021:CD013110. DOI: https://doi.org/10.1002/14651858.CD013110.pub2
Radtke T, Nevitt SJ, Hebestreit H, Kriemler S. Physical exercise training for cystic fibrosis. Cochrane Database Syst Rev 2017;2017:CD002768. DOI: https://doi.org/10.1002/14651858.CD002768.pub4
Osadnik CR, Gleeson C, McDonald VM, Holland AE. Pulmonary rehabilitation versus usual care for adults with asthma. Cochrane Database Syst Rev 2022;8:CD013485. DOI: https://doi.org/10.1002/14651858.CD013485.pub2
Li M, Mathur S, Chowdhury NA, et al. Pulmonary rehabilitation in lung transplant candidates. J Heart Lung Transplant 2013;32:626-32. DOI: https://doi.org/10.1016/j.healun.2013.04.002
Langer D, Burtin C, Schepers L, et al. Exercise training after lung transplantation improves participation in daily activity: a randomized controlled trial. Am J Transplant 2012;12:1584-92. DOI: https://doi.org/10.1111/j.1600-6143.2012.04000.x
Langer D. Rehabilitation in patients before and after lung transplantation. Respiration 2015;89:353-62. DOI: https://doi.org/10.1159/000430451
Kenn K, Gloeckl R, Soennichsen A, et al. Predictors of success for pulmonary rehabilitation in patients awaiting lung transplantation. Transplantation 2015;99:1072-7. DOI: https://doi.org/10.1097/TP.0000000000000472
Singer JP, Diamond JM, Gries CJ, et al. Frailty phenotypes, disability, and outcomes in adult candidates for lung transplantation. Am J Respir Crit Care Med 2015;192:1325-34. DOI: https://doi.org/10.1164/rccm.201506-1150OC
Wickerson L, Helm D, Gottesman C, et al. Telerehabilitation for lung transplant candidates and recipients during the COVID-19 pandemic: program evaluation. JMIR Mhealth Uhealth 2021;9:e28708. DOI: https://doi.org/10.2196/28708
Taito S, Yamauchi K, Kataoka Y. Telerehabilitation in subjects with respiratory disease: a scoping review. Respiratory Care 2021;66:686-98. DOI: https://doi.org/10.4187/respcare.08365
Tsutsui M, Gerayeli F, Sin DD. Pulmonary rehabilitation in a post-COVID-19 world: telerehabilitation as a new standard in patients with COPD. COPD 2021;16:379-91. DOI: https://doi.org/10.2147/COPD.S263031
Cox NS, Dal Corso S, Hansen H, et al. Telerehabilitation for chronic respiratory disease. Cochrane Database Syst Rev 2021;1:CD013040. DOI: https://doi.org/10.1002/14651858.CD013040.pub2
Mendes Xavier D, Lanza Galvão E, Aliane Fonseca A, et al. Effects of home-based pulmonary rehabilitation on dyspnea, exercise capacity, quality of life and impact of the disease in COPD patients: a systematic review. COPD 2022;19:18-46. DOI: https://doi.org/10.1080/15412555.2021.2020234
Wuytack F, Devane D, Stovold E, et al. Comparison of outpatient and home-based exercise training programmes for COPD: a systematic review and meta-analysis. Respirology 2018;23:272-83. DOI: https://doi.org/10.1111/resp.13224
Neves LF, Reis MHD, Gonçalves TR. Home or community-based pulmonary rehabilitation for individuals with chronic obstructive pulmonary disease: a systematic review and meta-analysis. Cad Saude Publica 2016;32:S0102-311X2016000602001. DOI: https://doi.org/10.1590/0102-311X00085915
Bourgeois N, Lands LC, Prévost K, et al. Virtual physical prehabilitation in lung transplant candidates: a proof-of-concept study. Transpl Int 2024;37:12355. DOI: https://doi.org/10.3389/ti.2024.12355

Ethics Approval

Ethical clearance was taken from the Institutional Ethics Committee, All India Institute of Medical Sciences (AIIMS), New Delhi-110029, with serial no. IECPG-754/23.12.2021 (dated 24.12.2021).

How to Cite



“Role of Hybrid Virtual Pulmonary Rehabilitation in Improving Performance Status of Patients Eligible for Lung Transplantation”. 2025. Monaldi Archives for Chest Disease, October. https://doi.org/10.4081/monaldi.2025.3342.